Clinical Trial Update: A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study in healthy female participants to assess the effect of TMC435 on the PK of the oral contraceptive Ovysmen; the study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ovysmen
• TMC435

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED